Cite
HARVARD Citation
Tanaka, T. et al. (2015). Use of simeprevir following pre‐emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12‐week pilot study. Journal of hepato-biliary-pancreatic sciences. pp. 144-150. [Online].